This morning, Johnson & Johnson (JNJ) reported fourth quarter earnings of $3.52 billion, or $1.23 per share, as revenue climbed to $18.36 billion. Excluding one-time items, the company would have earned $1.24 per share, topping Wall Street estimates. In the report, Johnson & Johnson said prescription drug sales climbed by 12%, consumer products sales rose by 2.8% and medical device sales dropped by 1%. For the full year, the company expects earnings in the range of $5.75 to $5.85 per share. Shares of JNJ were lower on Tuesday, slipping 2.3% today.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.